HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiangyi Meng Selected Research

iloperidone

1/2015Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
3/2014A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia.
2/2013Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial.
2/2013A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
1/2012Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
9/2011Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiangyi Meng Research Topics

Disease

28Alzheimer Disease (Alzheimer's Disease)
05/2016 - 01/2008
13Multiple Sclerosis
03/2021 - 05/2014
12Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022 - 12/2016
8Dementia (Dementias)
10/2013 - 01/2010
6Schizophrenia (Dementia Praecox)
01/2015 - 09/2011
6Parkinson Disease (Parkinson's Disease)
01/2013 - 01/2010
5Macular Degeneration (Age-Related Maculopathy)
11/2022 - 01/2021
4Relapsing-Remitting Multiple Sclerosis
10/2020 - 03/2015
3Psychomotor Agitation (Akathisia)
01/2015 - 01/2012
2Inflammation (Inflammations)
12/2022 - 01/2022
2Body Weight (Weight, Body)
05/2022 - 01/2015
2Pain (Aches)
11/2021 - 07/2019
2Psoriatic Arthritis
09/2021 - 01/2020
2Infections
11/2019 - 01/2019
2Disease Progression
10/2018 - 01/2013
2Sleepiness
01/2015 - 01/2012
2Dizziness (Lightheadedness)
01/2015 - 01/2012
2Tachycardia (Tachyarrhythmias)
02/2013 - 01/2012
2Psychotic Disorders (Schizoaffective Disorder)
02/2013 - 01/2012
2Type 2 Diabetes Mellitus (MODY)
10/2011 - 01/2010
2Cognitive Dysfunction
09/2011 - 02/2009
1Aneurysm (Aneurysms)
01/2022
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022
1Retinal Vasculitis
01/2022
1Ankylosing Spondylitis
01/2020
1Heart Failure
01/2020
1Urinary Tract Infections (Urinary Tract Infection)
11/2019
1Human Influenza (Influenza)
11/2019
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2019
1Pruritus (Itching)
07/2019
1Corneal Injuries
01/2019
1Hyperemia
01/2019
1Dysgeusia (Parageusia)
01/2019
1Mobility Limitation (Difficulty Walking)
10/2018
1Neoplasms (Cancer)
06/2015
1Sudden Death
02/2013
1Headache (Headaches)
02/2013
1Dyspepsia (Indigestion)
02/2013
1Cardiac Arrhythmias (Arrythmia)
02/2013
1Asthma (Bronchial Asthma)
03/2012
1Fatigue
01/2012
1Basal Ganglia Diseases (Basal Ganglia Disease)
01/2012
1Vomiting
04/2010
1Nausea
04/2010
1Albuminuria
01/2010

Drug/Important Bio-Agent (IBA)

28Rivastigmine (Exelon)FDA LinkGeneric
05/2016 - 01/2008
13Fingolimod Hydrochloride (FTY720)FDA Link
03/2021 - 05/2014
12secukinumabIBA
05/2022 - 12/2016
6iloperidoneFDA Link
01/2015 - 09/2011
5InterferonsIBA
12/2022 - 05/2014
5Cholinesterase Inhibitors (Anticholinesterases)IBA
12/2011 - 01/2008
4Capsules (Microcapsules)IBA
12/2011 - 01/2010
4Donepezil (Aricept)FDA LinkGeneric
01/2010 - 01/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2022 - 12/2021
3Glatiramer Acetate (Copaxone)FDA Link
10/2018 - 05/2014
3Antipsychotic Agents (Antipsychotics)IBA
01/2015 - 09/2011
3A-factor (Streptomyces)IBA
01/2015 - 01/2010
3Risperidone (Risperdal Consta)FDA LinkGeneric
01/2015 - 01/2012
3Memantine (Namenda)FDA Link
01/2015 - 02/2010
2Etanercept (Enbrel)FDA Link
05/2022 - 01/2017
2Immunoglobulin A (IgA)IBA
05/2022 - 01/2019
2Retinaldehyde (Retinal)IBA
01/2022 - 01/2021
2Pharmaceutical PreparationsIBA
01/2019 - 01/2013
2Sphingosine-1-Phosphate ReceptorsIBA
01/2019 - 05/2014
2Monoclonal AntibodiesIBA
12/2016 - 12/2016
2Aripiprazole (Abilify)FDA Link
01/2015 - 03/2014
2Olanzapine (Zyprexa)FDA Link
01/2015 - 03/2014
2ziprasidone (Geodon)FDA Link
02/2013 - 01/2012
2Antihypertensive Agents (Antihypertensives)IBA
10/2011 - 01/2010
2Valsartan (Vals)FDA Link
01/2010 - 07/2007
1Interleukin-8 (Interleukin 8)IBA
12/2022
1NF-kappa B (NF-kB)IBA
12/2022
1Mitogen-Activated Protein KinasesIBA
12/2022
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
12/2022
1Caspase 3 (Caspase-3)IBA
12/2022
1Interleukin-6 (Interleukin 6)IBA
12/2022
1brolucizumabIBA
01/2022
1afliberceptIBA
01/2022
1Neurofibromin 2 (Merlin)IBA
01/2022
1Tumor Necrosis Factor InhibitorsIBA
09/2021
1EnalaprilFDA LinkGeneric
01/2020
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2020
1Interferon beta-1aFDA Link
10/2018
1CytokinesIBA
12/2016
1Interleukin-17 (Interleukin 17)IBA
12/2016
1Quetiapine Fumarate (Seroquel)FDA Link
02/2013
1Omalizumab (Xolair)FDA Link
03/2012
1Haloperidol (Haldol)FDA LinkGeneric
01/2012
1AlbuminsIBA
10/2011
1TabletsIBA
06/2009

Therapy/Procedure

17Therapeutics
11/2022 - 07/2007
13Activities of Daily Living (ADL)
05/2016 - 01/2010
9Transdermal Patch
12/2011 - 06/2009
4Injections
03/2021 - 01/2018
2Biological Therapy
05/2022 - 01/2017
1Ventriculoperitoneal Shunt
01/2022
1General Anesthesia
06/2015
1Laryngoscopes
06/2015
1Gas Lasers
06/2015
1Duration of Therapy
05/2014